Biopharmaceutics Classification System
Results: 35
# | Item |
---|---|
31 | Guidance for Industry Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification SystemAdd to Reading ListSource URL: www.fda.govLanguage: English |
32 | Guidance for Industry Dissolution Testing of Immediate Release Solid Oral Dosage Forms U.S. Department of Health and Human Services Food and Drug AdministrationAdd to Reading ListSource URL: www.fda.govLanguage: English |
33 | Guidance for Industry #171 - Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles, February 16, 2006Add to Reading ListSource URL: www.fda.govLanguage: English |
34 | Microsoft Word - Comprehensive List Of Guidances_3[removed]docAdd to Reading ListSource URL: www.fda.govLanguage: English |
35 | Guidance for Industry Waiver of In Vivo Bioavailability and Bioequivalence Studies forAdd to Reading ListSource URL: www.fda.govLanguage: English |